Alan Portela, CEO of AirStrip, has more than 25 years of experience in bringing medical technology solutions to market. Portela originally joined AirStrip as a senior advisor and member of the board of directors prior to his appointment as CEO in 2011. Prior to joining AirStrip, he was CEO and principal of Hybrid Clinical Transformation, LLC, where he developed EHR adoption strategies for the U.S. Military Health System and much of the Veterans Health Administration. He also served as president and chief strategist at CliniComp, Intl., and in senior executive roles in several innovative healthcare technology and service organizations.
AirStrip provides a vendor and data source-agnostic, enterprise-wide mobile interoperability platform that advances care collaboration and serves as a catalyst for health system innovation. Here he discusses mHealth trends; why and how it needs to change; interoperability; security and protecting against breach;and the biggest issues facing healthcare in the next year.
Can you tell us about yourself and your background prior to starting AirStrip? Why healthcare?
Prior to joining AirStrip, I was the president at CliniComp and responsible for the implementation of high acuity EHR systems at the U.S Military Health System, Veterans Health Administration (VA) and a number of prestigious healthcare organizations in the private sector. In my more than 25 years of experience in the healthcare industry, I have held several senior executive roles with innovative healthcare technology vendors and helped pioneer an mHealth company more than a decade ago that came out of UCLA Medical Center Department of Neurosurgery (Global Care Quest). Leading the industry via disruptive and continuous innovation has become a true passion. Each day I see how technology improves patient care, and I enjoy being an active part of that transformation.
What do you think the mHealth industry needs to change to better support doctors and patients today?
Mobile technology and clinical decision support tools will undoubtedly be the biggest contributors to the needed clinical transformation revolution, providing physicians with a means to deliver proactive quality care to millions of patients throughout the continuum of care. However, for clinical transformation to occur, the industry needs to establish – and enforce – interoperable standards so that data and technology can move seamlessly across systems and provide clinically relevant patient information at the moment of care regardless of where the caregivers and the patients are. Interoperability will remove the data silos that currently impede access to information, and allow for clinical decision support that lets clinicians provide the best care, improving overall patient outcomes and well-being. The fact that legacy vendors are not sharing data means that innovation is being stifled. Unfortunately, both the federal government and a handful of legacy vendors seem to be driving us deeper into the crisis by carrying the flag of interoperability, but only limiting requirements to minimal clinical data sets, which do not contribute to the move from volume to value-based reimbursement.